These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28690829)

  • 1. A simple mathematical approach to the analysis of polypharmacology and polyspecificity data.
    Maggiora G; Gokhale V
    F1000Res; 2017; 6():. PubMed ID: 28690829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.
    Cortés-Cabrera A; Morris GM; Finn PW; Morreale A; Gago F
    Br J Pharmacol; 2013 Oct; 170(3):557-67. PubMed ID: 23826885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method.
    Nam S; Lee S; Park S; Lee J; Park A; Kim YH; Park T
    Bioinformatics; 2022 Jan; 38(2):444-452. PubMed ID: 34515762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
    Barneh F; Jafari M; Mirzaie M
    Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local Alignment of Ligand Binding Sites in Proteins for Polypharmacology and Drug Repositioning.
    Brylinski M
    Methods Mol Biol; 2017; 1611():109-122. PubMed ID: 28451975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacology: challenges and opportunities in drug discovery.
    Anighoro A; Bajorath J; Rastelli G
    J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
    Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
    Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining significant substructure pairs for interpreting polypharmacology in drug-target network.
    Takigawa I; Tsuda K; Mamitsuka H
    PLoS One; 2011 Feb; 6(2):e16999. PubMed ID: 21373195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.
    Wathieu H; Issa NT; Byers SW; Dakshanamurthy S
    Curr Pharm Des; 2016; 22(21):3097-108. PubMed ID: 26907947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
    Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
    Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into polypharmacology from drug-domain associations.
    Moya-García AA; Ranea JA
    Bioinformatics; 2013 Aug; 29(16):1934-7. PubMed ID: 23740740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of Drug Sensitivity and Selectivity to Predict Synergistic Drug Combinations and Target Coaddictions in Cancer.
    Jaiswal A; Yadav B; Wennerberg K; Aittokallio T
    Methods Mol Biol; 2019; 1888():205-217. PubMed ID: 30519949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacology: promises and new drugs in 2022.
    Ryszkiewicz P; Malinowska B; Schlicker E
    Pharmacol Rep; 2023 Aug; 75(4):755-770. PubMed ID: 37278927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacology - foe or friend?
    Peters JU
    J Med Chem; 2013 Nov; 56(22):8955-71. PubMed ID: 23919353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Similar Binding Sites to Detect Distant Polypharmacology.
    Jalencas X; Mestres J
    Mol Inform; 2013 Dec; 32(11-12):976-90. PubMed ID: 27481143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.